Skip to content

Online Dance Versus Therapeutic Exercise for Parkinson Disease.

Online Dance Versus Online Therapeutic Exercise on Quality of Life - A Protocol for a Randomized Controlled Trial Investigating Social Telerehabilitation Efficacy in Parkinson's Disease.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05910216
Enrollment
40
Registered
2023-06-18
Start date
2023-10-16
Completion date
2024-06-30
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease, Dance, Physiotherapy, Telehealth, Telerehabilitation

Brief summary

This is a randomized clinical trial in an online format, which will only include people with PD randomly divided into two groups: Group 1 - Social Telerehabilitation with Dance and Music Group 2 - Social Telerehabilitation with Multimodal Therapeutic Exercise and Music

Interventions

OTHERDance & Music (Online)

This is a social telerehabilitation with dance and music. It will include artistic form, imageries using scenic arts, imageries using aspects of theater and storytelling, movement improvisation, choreography and sequence of movements, complex dance movements, fluidity of movement or connection between one movement and another, rhythmicity and/or movement built with music. It will include instructions for motor learning, music, and socialization

OTHERMultimodal Therapeutic Exercise & Music (Online)

This is a social telerehabilitation with multimodal therapeutic Exercise and Music. It is restricted to the execution of movements within series and standardized and fixed repetitions, with a background music. It will not include dance. It will include instructions for motor learning, music, and socialization.

Sponsors

Federal University of Health Science of Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled trial with two groups

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of idiopathic PD according to the clinical criteria of the London Brain Bank Criteria (2006); * Age between 40-90 years; * A minimum score of 18 in the Montreal Cognitive Assessment; * Drug therapy/exercise stable for at least four weeks before the study starts; * Agreement to participate in the study according to the Informed Consent Form.

Exclusion criteria

* Auditory and/or visual disturbances that compromise understanding simple commands; * Access to the internet and a device to access online classes; * A house member and/or caregiver at home for supervision during the entire experiment, including evaluations and interventions. For patients scoring less than 2.5 points on the modified Hoehn and Yahr Scale (indicating mild disease impairment, independence in daily living activities, and no risk of falls), the requirement for household member supervision may be waived.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of Quality of lifeChange from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)Quality of life measured by Parkinson's Disease Questionnaire (PDQ-39). Scores range from 0-100 (100 = maximum level of problems).
Assessment of Well-beingChange from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)Well-being measured by the scale Positive and Negative Affect Scale (PANAS). scores range from 10 - 50, a higher score indicates more of a positive affect.

Secondary

MeasureTime frameDescription
Assessment of Symptoms of AnxietyChange from Pre to Post treatment (12 weeks)Symptoms of Anxiety measured by the Parkinson Anxiety Scale (PAS). Scores range from 0-48 (48= maximum level of problems).
Assessment of Motor symptoms severityChange from Pre to Post treatment (12 weeks) and FOLLOW-UP (after 4 weeks of study ending)Motor symptoms severity measured by the scale Unified Parkinson's disease rating scale, motor subscale (UPDRS III). Part III: Motor examination: 18 items. Score range: 0-132, 32 and below is mild, 59 and above is severe.
Feasibility (self-perceptions)Change from Pre to Post treatment (12 weeks)Self-perceptions (feasibility) of technology usability, socialization and benefits of interventions based on a structured interview.
Assessment of Attention and Memory RecognitionChange from Pre to Post treatment (12 weeks)Executive function by means attention and memory recognition measureb by Online Attention Test (OAT) and Recognition Memory Test (RMT).
Assessment of Functional lower extremity strengthChange from Pre to Post treatment (12 weeks)Functional lower extremity strength measured by the Five times sit to stand test (FTSTS). The time to complete the test is measured, where lower time to perform sit to stand represents better functional lower extremity strength

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026